Skip to content

Author

Peng-Peng Zhang

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

A programmed cell death learning signature predicts immunotherapy response and identifies AP1S1 as a regulator of immune exclusion in breast cancer.

This study establishes the PCDsig developed is a potential prognostic and predictive biomarker for breast cancer and provides the first evidence of AP1S1 as a core immunomodulatory oncogene that mediates immune exclusion.

Gui-Xin Wang, Jun Cao, Parhat Kaysar et al. · 0 citations
Open access Jul 2026

Dissecting liver cancer stem cell heterogeneity via single-cell RNA sequencing and developing a stemness-based prognostic model.

The C3C4-SPS model provides a novel tool for prognostic assessment and potentially individualized therapy targeting stemness-associated features in hepatocellular carcinoma and performed robustly in ROC and PCA validation.

Jinhan Zhao, Jiaqi Feng, Peng-Peng Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.